Chawla R K, Heymsfield S B, Wadsworth A A, Shoji M, Rudman D
Cancer Res. 1977 Mar;37(3):873-8.
Patient J. B. with metastatic carcinoma of the colon excreted 0.5 to 1.0 g protein daily, about one-third of which was in Molecular Weight Class 30,000 to 60,000. The major component of this class was isolated by gel filtration and ion-exchange chromatography. The purified protein, labeled JBB5, contained about 11% sialic acid, 8% hexose, and 4% hexosamine. Its molecular weight was between 51,000 and 59,000. It did not react detectably with antisera to any of the recognized normal human plasma proteins. A specific antiserum to JBB5 was raised in the rabbit. Urine from 4% of subjects with nonneoplastic illnesses reacted in double immunodiffusion with anti-JBB5. Thirty-three % positive reactions were obtained with urines from patients with advanced neoplastic disease, the percentage varying from 64% in metastatic cancer of the pancreas to 15% in chronic lymphocytic leukemia.
患有结肠癌转移的患者J.B.每天排泄0.5至1.0克蛋白质,其中约三分之一处于分子量30,000至60,000的类别中。该类别的主要成分通过凝胶过滤和离子交换色谱法分离出来。纯化后的蛋白质标记为JBB5,含有约11%的唾液酸、8%的己糖和4%的己糖胺。其分子量在51,000至59,000之间。它与针对任何公认的正常人血浆蛋白的抗血清均未产生可检测到的反应。在兔子体内产生了针对JBB5的特异性抗血清。4%的非肿瘤性疾病患者的尿液在双向免疫扩散试验中与抗JBB5发生反应。晚期肿瘤疾病患者的尿液中有33%呈阳性反应,该百分比在胰腺癌转移患者中为64%,在慢性淋巴细胞白血病患者中为15%。